The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
VYCO · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | VYCO | WST | MSA | SIGA |
|---|---|---|---|---|
| Moat Score (0–100) | 74 | 75 (highest) | 74 | 73 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 70 | 44 | 90 (highest) | 15 |
| Pricing power | 100 (highest) | 54 | 77 | 91 |
| Returns on capital | — | 91 | 60 | 96 (highest) |
| Balance-sheet safety | 100 (highest) | 100 (highest) | 66 | 100 (highest) |
| Capital allocation | 24 | 83 (highest) | 74 | 63 |
| No price data | 263% above value if growth stopped today | 232% above value if growth stopped today | 66% below value if growth stopped today (largest discount to value if growth stopped today) | |
| Market cap | $2.3M | $23.6B | $6.8B | $223M |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |